The compound continues to be researched in the patent literature for its anxiolytic properties and lessened sedative, hypnotic, and ataxic facet-effects, but it does not seem like licensed for healthcare use. ?ukasik-G?ebocka et alPyrazolam is often a triazolo-BZD with evidently little details, structurally comparable to alprazolam but is brominate